|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online June 28, 2004
doi: 10.1242/10.1242/dev.01213
1 Department of Molecular and Cellular Oncology, The University of Texas M. D.
Anderson Cancer Center, Houston, TX 77030, USA
2 Department of Biochemistry and Molecular Biology, The University of Texas M.
D. Anderson Cancer Center, Houston, TX 77030, USA
* Author for correspondence (e-mail: rkumar{at}mdanderson.org)
Accepted 8 March 2004
Emerging data suggest that metastasis-associated protein 1 (MTA1) represses ligand-dependent transactivation functions of estrogen receptor-alpha in cultured breast cancer cells and that MTA1 is upregulated in human breast tumors. However, the role of MTA1 in tumorigenesis in a physiologically relevant animal system remains unknown. To reveal the role of MTA1 in mammary gland development, transgenic mice expressing MTA1 under the control of the mouse mammary tumor virus promoter long terminal repeat were generated. Unexpectedly, we found that mammary glands of these virgin transgenic mice exhibited extensive side branching and precocious differentiation because of increased proliferation of ductal and alveolar epithelial cells. Mammary glands of virgin transgenic mice resemble those from wild-type mice in mid-pregnancy and inappropriately express ß-casein, cyclin D1 and ß-catenin protein. Increased ductal growth was also observed in the glands of ovariectomized female mice, as well as of transgenic male mice. MTA1 dysregulation in mammary epithelium and cancer cells triggered downregulation of the progesterone receptor-B isoform and upregulation of the progesterone receptor-A isoform, resulting in an imbalance in the native ratio of progesterone receptor A and B isoforms. MTA1 transgene also increased the expression of progesterone receptor-A target genes Bcl-XL (Bcl2l1) and cyclin D1 in mammary gland of virgin mice, and, subsequently, produced a delayed involution. Remarkably, 30% of MTA1 transgenic females developed focal hyperplastic nodules, and about 7% exhibited mammary tumors within 18 months. These studies establish, for the first time, a potential role of MTA1 in mammary gland development and tumorigenesis. The underlying mechanism involves the upregulation of progesterone receptor A and its targets, Bcl-XL and cyclin D1.
Key words: Mammary gland development, Transgenic mice, MTA1, Progesterone receptors, Cyclin D1, Bcl-XL, Bcl2l1
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
Related articles in Development:
This article has been cited by other articles:
|
|
 |
|
  R. Kumar, H. Zhang, C. Holm, R. K. Vadlamudi, G. Landberg, and S. K. Rayala Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen Clin. Cancer Res., June 15, 2009; 15(12): 4123 - 4130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dimple, S. S. Nair, R. Rajhans, P. R. Pitcheswara, J. Liu, S. Balasenthil, X.-F. Le, M. E. Burow, N. Auersperg, R. R. Tekmal, et al. Role of PELP1/MNAR Signaling in Ovarian Tumorigenesis Cancer Res., June 15, 2008; 68(12): 4902 - 4909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Arendt and L. A. Schuler Prolactin Drives Estrogen Receptor-{alpha}-Dependent Ductal Expansion and Synergizes with Transforming Growth Factor-{alpha} to Induce Mammary Tumors in Males Am. J. Pathol., January 1, 2008; 172(1): 194 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bagheri-Yarmand, S. Balasenthil, A. E. Gururaj, A. H. Talukder, Y.-H. Wang, J. H. Lee, Y. S. Kim, X. Zhang, D. M. Jones, L. J. Medeiros, et al. Metastasis-Associated Protein 1 Transgenic Mice: A New Model of Spontaneous B-Cell Lymphomas Cancer Res., August 1, 2007; 67(15): 7062 - 7067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rajhans, S. Nair, A. H. Holden, R. Kumar, R. R. Tekmal, and R. K. Vadlamudi Oncogenic Potential of the Nuclear Receptor Coregulator Proline-, Glutamic Acid-, Leucine-Rich Protein 1/Modulator of the Nongenomic Actions of the Estrogen Receptor Cancer Res., June 1, 2007; 67(11): 5505 - 5512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Manavathi and R. Kumar Metastasis Tumor Antigens, an Emerging Family of Multifaceted Master Coregulators J. Biol. Chem., January 19, 2007; 282(3): 1529 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, R. R. Singh, A. H. Talukder, and R. Kumar Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway Genes & Dev., November 1, 2006; 20(21): 2943 - 2948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cabodi, A. Tinnirello, P. Di Stefano, B. Bisaro, E. Ambrosino, I. Castellano, A. Sapino, R. Arisio, F. Cavallo, G. Forni, et al. p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene-Dependent Breast Tumorigenesis. Cancer Res., May 1, 2006; 66(9): 4672 - 4680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Gururaj, R. R. Singh, S. K. Rayala, C. Holm, P. den Hollander, H. Zhang, S. Balasenthil, A. H. Talukder, G. Landberg, and R. Kumar MTA1, a transcriptional activator of breast cancer amplified sequence 3 PNAS, April 25, 2006; 103(17): 6670 - 6675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, L. C. Stephens, and R. Kumar Metastasis Tumor Antigen Family Proteins during Breast Cancer Progression and Metastasis in a Reliable Mouse Model for Human Breast Cancer Clin. Cancer Res., March 1, 2006; 12(5): 1479 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kumar, A. E. Gururaj, R. K. Vadlamudi, and S. K. Rayala The Clinical Relevance of Steroid Hormone Receptor Corepressors Clin. Cancer Res., April 15, 2005; 11(8): 2822 - 2831. [Abstract] [Full Text] [PDF]
|
|
